News Author: Brian Hoyle Publish date: April 3, 2016
Liraglutide may work to decrease activation of brain sites related to desire for unhealthy foods in patients with type 2 diabetes.
News Author: Brian Hoyle Publish date: April 2, 2016
News Author: Brian Hoyle Publish date: April 2, 2016
Key clinical point: As a faster-acting mealtime insulin, faster aspart may mimic more closely the physiologic mealtime insulin response of the hea...
News Author: Brian Hoyle Publish date: February 28, 2016
News Author: Brian Hoyle Publish date: February 26, 2016
Key clinical point: Brain atrophy could be a clinically useful and relevant measure in primary progressing multiple sclerosis.
News Author: Brian Hoyle Publish date: February 26, 2016
Key clinical point: Fingolimod shows signs that it may improve gait in MS patients who are naive to treatment or have only received first-line the...
News Author: Brian Hoyle Publish date: February 25, 2016
News Author: Brian Hoyle Publish date: February 24, 2016
Key clinical point: Certain subgroups of patients may respond better to treatment
Major finding: Reduction in the risk of confirmed disability pr...
News Author: Brian Hoyle Publish date: February 24, 2016
Key clinical point: Blood-borne biomarkers of MS relapse and treatment efficacy were identified.
Major finding: RGC-32, FasL, and IL-21 are potent...
News Author: Brian Hoyle Publish date: February 24, 2016
Treatment for MS should continue even when disability is advanced.
News Author: Brian Hoyle Publish date: February 23, 2016
The pattern of the CSF biomarkers, which correspond to the extent of gray matter damage, has potential value in stratifying patients in terms of disea...
News Author: Brian Hoyle Publish date: February 21, 2016
Key clinical point: Anti-m<scaps>ü</scaps>llerian hormone may be a biologic marker of MS progression in women.
News Author: Brian Hoyle Publish date: February 21, 2016
Treadmill exercise can at least transiently improve cognitive impairment in patients with multiple sclerosis.
News Author: Brian Hoyle Publish date: November 19, 2015
A variety of new, repurposed, and reformulated compounds have made their way into clinical trials for systemic lupus erythematosus, including a subcut...
News Author: Brian Hoyle Publish date: November 18, 2015
Key clinical point: Patients with pulmonary arterial hypertension and connective tissue disease can benefit from riociguat treatment.
Major findin...
